<DOC>
	<DOCNO>NCT00890045</DOCNO>
	<brief_summary>Compare HeRO Vascular Access Device conventional ePTFE graft .</brief_summary>
	<brief_title>Hemodialysis Reliable Outflow ( HeRO ) Vascular Access Patency Study</brief_title>
	<detailed_description>The purpose study compare HeRO Vascular Access Device conventional ePTFE graft . It hypothesize HeRO patency comparable conventional ePTFE graft control .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<criteria>1 . 21 year age old . 2 . Male nonpregnant female . 3 . Life expectancy 2 year . 4 . Endstage renal disease require arm vascular prosthesis dialysis access . 5 . Ability understand provide write informed consent . 6 . Willing able cooperate followup examination . 7 . Subject 's upper arm use implant ( Note : The GVAS device must implant upper arm , Control group graft implant upper low arm location. ) . 8 . Able follow daily aspirin and/or oral anticoagulation/antiplatelet regimen . 1 . Potential graft target artery less 3 mm diameter determine suitable preoperative measure . 2 . Documented history drug abuse within six month . 3 . `` Planned '' concomitant surgical procedure previous major surgery within 30 day , exclude vascular access related procedure . 4 . Currently treat another investigational device drug . 5 . Known bleed diathesis hypercoagulable state . 6 . Peripheral white blood cell count 1500/mm3 ( 1.5 K/mm3 ) platelet count 50,000/mm3 ( 50 K/mm3 ) . 7 . Degenerative connective tissue disease , e.g. , Marfan 's Ehlers Danlos Syndrome . Subjects Lupus Erythematosus may include . 8 . Subjects know suspected concomitant bacterial , fungal , viral , parasitic infection . Subjects Hepatitis B may include . Subjects HIV + CD4 count &lt; 200 exclude . 9 . Severe underlying comorbidity immediate lifethreatening condition . 10 . Subjects condition , opinion investigator , could preclude evaluation response completion followup affect subject safety . 11 . Subjects candidate autologous fistula . 12 . Subjects schedule renal transplant within next 12 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Vascular access hemodialysis</keyword>
	<keyword>ePTFE graft</keyword>
	<keyword>Graft-eligible</keyword>
	<keyword>Long-term vascular access hemodialysis</keyword>
</DOC>